For research that focuses on leukaemia, lymphoma or blood related diseases
- The scheme is open to researchers in all faculties and institutes of the University of Tasmania; departments within Tasmanian hospitals; and the Department of Health and Human Services.
- The research must focus on leukaemia, lymphoma or blood related diseases. It includes population health strategies, medical research, clinical and psychosocial care.
- An individual can only be listed on one grant as a lead chief investigator (CI) at any one time. Achievement of deliverables on previous DCLFofT grants will be considered when assessing requests.
- Closing date and time of the scheme, formatting length and supporting documentation requirements must be strictly adhered to. Applicants not meeting these requirements will not be eligible for funding.
- Quality of the research proposal, including feasibility and budget (50%)
- Research capacity, including track record and research team (25%)
- Applications with an early career researcher as the lead investigator will receive additional 20% weighting in this category. Please indicate on the form if you are an early career researcher. This includes those who obtained their PhD or highest degree ≤ 5 FTE years ago or who have had no grants as a lead investigator (>$10,000). If you are unsure whether you meet this criterion, please contact DCLFofT.
- Research significance and innovation, including alignment with the strategic direction of DCLFofT and broader contribution to the field of research (25%).
- Full electronic applications must be submitted to firstname.lastname@example.org.
- Applications will be distributed to the relevant review panel.
- Members of the panel will individually assess, score and rank applications.
- Ranked applications will then be discussed at a DCLFofT meeting to consolidate a score and ranking.
- The committee of DCLFofT will then make a funding recommendation.
- Applicants will be informed of their outcome in early 2020.
Conditions of Grant
- The term of each funding round will be 12 months.
- Research funding must be spent, as outlined in the application, by the project close date. Unspent funds will be reclaimed.
- A Final Report must be submitted.
- No part of the funding is to be used for external conference attendance.
- If a sole CI leaves their current employment, then the grant must be relinquished.
- Funding cannot be used for salaries, or to fund a Research Higher Degree candidate’s stipend or fees.
Funding is subject to investigators obtaining relevant ethics committee approvals.
Applications close 1st March 2020